Overview

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

Status:
Enrolling by invitation
Trial end date:
2022-02-20
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of Acipimox or placebo to exercise on growth hormone release and ghrelin secretion in bulimic patients and in healthy women. Two groups of participants will receive Acipimox together with exercise versus identical placebo with exercise.
Phase:
Phase 2
Details
Lead Sponsor:
Charles University, Czech Republic
Treatments:
Acipimox